-
Yesterday evening, Genentech released results of a midstage clinical test of its colorectal cancer drug Avastin in combination with chemotherapy.
FORBES: Magazine Article
-
Initially, a court argued that Apotex's generic didn't run afoul of Glaxo's patents because some of the clinical trials done to test the drug essentially put it in the public domain.
FORBES: The Drug To Watch
-
Clinical trials are expected to begin later this year to test the drug's effectiveness in humans.
CNN: STORY HIGHLIGHTS
-
The new outfit, Transcelerate Biopharma, was created out of a regular meeting of drug company research chiefs and will focus on five areas where the clinical trials that are used to test medicines wastefully duplicate procedures like training physicians, running websites, or creating procedures to document the benefits and side effects of new medicines.
FORBES: Ten Pharmas Aim To Cut Red Tape To Speed Drug Development